<code id='C701A0375F'></code><style id='C701A0375F'></style>
    • <acronym id='C701A0375F'></acronym>
      <center id='C701A0375F'><center id='C701A0375F'><tfoot id='C701A0375F'></tfoot></center><abbr id='C701A0375F'><dir id='C701A0375F'><tfoot id='C701A0375F'></tfoot><noframes id='C701A0375F'>

    • <optgroup id='C701A0375F'><strike id='C701A0375F'><sup id='C701A0375F'></sup></strike><code id='C701A0375F'></code></optgroup>
        1. <b id='C701A0375F'><label id='C701A0375F'><select id='C701A0375F'><dt id='C701A0375F'><span id='C701A0375F'></span></dt></select></label></b><u id='C701A0375F'></u>
          <i id='C701A0375F'><strike id='C701A0375F'><tt id='C701A0375F'><pre id='C701A0375F'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:52786
          Sammy Kimball for STAT

          Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

          advertisement

          For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          knowledge

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Study: Lilly Alzheimer's therapy slowed patients' cognitive decline
          Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

          EvanVucci/APAnewtreatmentforAlzheimer’sdiseasedevelopedbyEliLillyslowedpatients’rateofcognitiveandfu

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Private equity could exacerbate cardiology's overuse problem, experts fear

          AdobeCoronarystentingis,bysomemeasures,themostoverusedprocedureinhospitals.Theproblemcoststhehealths